Elizabeth Esparaz, MD
Ophthalmology · Kent, OHNPI 1053654004
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,925 of the $9,783 with a category attached, or 60.6%. Regeneron Healthcare Solutions, Inc. accounts for 62.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2021 at $5,805 and has fallen 88.8% since, to $648 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $160.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$6K
- Amgen$2K
- Apellis Pharmaceuticals, Inc.$396
- Cardinal Health 110 LLC$275
- Alimera Sciences, Inc.$157
- Glaukos Corporation$150
- plus $600 from 12 others
What the payments were for
- Consulting fees$5,92561%
- Speaking & faculty fees$2,06621%
- Food & beverage$1,77818%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $6,113 |
| Amgen(2 entities) | 3 | $2,092 |
| Apellis Pharmaceuticals, Inc. | 10 | $396 |
| Cardinal Health 110 LLC | 1 | $275 |
| Alimera Sciences, Inc. | 4 | $157 |
| Glaukos Corporation | 1 | $150 |
| AbbVie(2 entities) | 6 | $127 |
| Astellas Pharma US Inc | 5 | $90 |
| Mallinckrodt Hospital Products Inc. | 3 | $71 |
| Coopervision Inc. | 1 | $64 |
| Genentech USA, Inc. | 3 | $55 |
| Harrow Eye, LLC | 2 | $51 |
| Alcon | 2 | $50 |
| Rayner Intraocular Lenses Limited | 2 | $30 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $16 |
| Novartis | 1 | $14 |
| Kala Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$5,775
- TEPEZZA$2,048
- iStent inject W$150
- Empaveli$122
How this compares
$9,783 in reported general payments places this provider in the 90th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 29 | $1,257 |
| ErythromycinErythromycin Base | 119 | $1,234 |
| Ketorolac Tromethamine | 24 | $489 |
| Latanoprost | 34 | $380 |
| Timolol Maleate | 29 | $332 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $310 |
| Dorzolamide Hcl | 19 | $189 |
| Brimonidine Tartrate | 16 | $139 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Kent
- Matthew WillettKent$47K
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
- Amy MillerDayton$526K
- Sunil SrivastavaCleveland$508K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.